Biktarvy, a new HIV combo pill recently approved by the FDA

This week, the FDA granted approval of Gilead Science’s single-tablet combo pill of bictegravir, emtricitabine (FTC) and tenofovir alafenamide (TAF) named Biktarvy. Read on for additional information about what we … Read More →